Cargando…

Design and Synthesis of Carbothioamide/Carboxamide-Based Pyrazoline Analogs as Potential Anticancer Agents: Apoptosis, Molecular Docking, ADME Assay, and DNA Binding Studies

[Image: see text] To discover anticancer drugs with novel structures and expand our research scope, pyrazoline derivatives (3a–3l) were designed and synthesized through cyclization of chalcones with thiosemicarbazide/semicarbazide in CH(3)COOH as a solvent. All newly synthesized pyrazoline derivativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Rana, Manish, Faizan, Md Imam, Dar, Sajad Hussain, Ahmad, Tanveer, Rahisuddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260921/
https://www.ncbi.nlm.nih.gov/pubmed/35811873
http://dx.doi.org/10.1021/acsomega.2c02033
_version_ 1784742150449135616
author Rana, Manish
Faizan, Md Imam
Dar, Sajad Hussain
Ahmad, Tanveer
Rahisuddin,
author_facet Rana, Manish
Faizan, Md Imam
Dar, Sajad Hussain
Ahmad, Tanveer
Rahisuddin,
author_sort Rana, Manish
collection PubMed
description [Image: see text] To discover anticancer drugs with novel structures and expand our research scope, pyrazoline derivatives (3a–3l) were designed and synthesized through cyclization of chalcones with thiosemicarbazide/semicarbazide in CH(3)COOH as a solvent. All newly synthesized pyrazoline derivatives were fully characterized using several spectroscopic experiments such as (1)H, (13)C NMR, FT-IR spectroscopy, and mass analysis. By HPLC, the purity of all analogs was found above 95% and both lead compounds (3a and 3h) were also validated by HRMS. Anticancer activity of synthesized pyrazoline derivatives (3a–3l) was investigated by the MTT assay against the human lung cancer cell (A549), human cervical cancer cell (HeLa), and human primary normal lung cells (HFL-1). Staurosporine (STS) was used as a standard drug. The anticancer results showed that two potent analogs 3a and 3h exhibit excellent activity against A549 (IC(50) = 13.49 ± 0.17 and 22.54 ± 0.25 μM) and HeLa cells (IC(50) = 17.52 ± 0.09 and 24.14 ± 0.86 μM) and low toxicity against the HFL-1 (IC(50) = 114.50 ± 0.01 and 173.20 ± 10 μM). The flow cytometry was further used to confirm the anticancer activity of potent derivatives against the A549 cancer cell line. DNA binding interaction of anticancer agents 3a and 3h with Ct-DNA has been carried out by absorption, fluorescence, EtBr (dye displacement assay), circular dichroism, cyclic voltammetry and time-resolved fluorescence, which showed noncovalent binding mode of interaction. Anticancer activity of both lead compounds (3a and 3h) may be attributed to DNA binding. The evaluation of the antioxidant potential of pyrazoline analogs 3a and 3h by 2,2-diphenyl-1-picrylhydrazyl free radical showed promising antioxidant activity with IC(50) values of 0.132 ± 0.012 and 0.215 ± 0.025 μg/mL, respectively. In silico molecular docking of pyrazoline derivatives was also performed using autodock vina software against the DNA hexamer with PDB ID: 1Z3F and ADMET properties to explore their best hits.
format Online
Article
Text
id pubmed-9260921
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-92609212022-07-08 Design and Synthesis of Carbothioamide/Carboxamide-Based Pyrazoline Analogs as Potential Anticancer Agents: Apoptosis, Molecular Docking, ADME Assay, and DNA Binding Studies Rana, Manish Faizan, Md Imam Dar, Sajad Hussain Ahmad, Tanveer Rahisuddin, ACS Omega [Image: see text] To discover anticancer drugs with novel structures and expand our research scope, pyrazoline derivatives (3a–3l) were designed and synthesized through cyclization of chalcones with thiosemicarbazide/semicarbazide in CH(3)COOH as a solvent. All newly synthesized pyrazoline derivatives were fully characterized using several spectroscopic experiments such as (1)H, (13)C NMR, FT-IR spectroscopy, and mass analysis. By HPLC, the purity of all analogs was found above 95% and both lead compounds (3a and 3h) were also validated by HRMS. Anticancer activity of synthesized pyrazoline derivatives (3a–3l) was investigated by the MTT assay against the human lung cancer cell (A549), human cervical cancer cell (HeLa), and human primary normal lung cells (HFL-1). Staurosporine (STS) was used as a standard drug. The anticancer results showed that two potent analogs 3a and 3h exhibit excellent activity against A549 (IC(50) = 13.49 ± 0.17 and 22.54 ± 0.25 μM) and HeLa cells (IC(50) = 17.52 ± 0.09 and 24.14 ± 0.86 μM) and low toxicity against the HFL-1 (IC(50) = 114.50 ± 0.01 and 173.20 ± 10 μM). The flow cytometry was further used to confirm the anticancer activity of potent derivatives against the A549 cancer cell line. DNA binding interaction of anticancer agents 3a and 3h with Ct-DNA has been carried out by absorption, fluorescence, EtBr (dye displacement assay), circular dichroism, cyclic voltammetry and time-resolved fluorescence, which showed noncovalent binding mode of interaction. Anticancer activity of both lead compounds (3a and 3h) may be attributed to DNA binding. The evaluation of the antioxidant potential of pyrazoline analogs 3a and 3h by 2,2-diphenyl-1-picrylhydrazyl free radical showed promising antioxidant activity with IC(50) values of 0.132 ± 0.012 and 0.215 ± 0.025 μg/mL, respectively. In silico molecular docking of pyrazoline derivatives was also performed using autodock vina software against the DNA hexamer with PDB ID: 1Z3F and ADMET properties to explore their best hits. American Chemical Society 2022-06-23 /pmc/articles/PMC9260921/ /pubmed/35811873 http://dx.doi.org/10.1021/acsomega.2c02033 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Rana, Manish
Faizan, Md Imam
Dar, Sajad Hussain
Ahmad, Tanveer
Rahisuddin,
Design and Synthesis of Carbothioamide/Carboxamide-Based Pyrazoline Analogs as Potential Anticancer Agents: Apoptosis, Molecular Docking, ADME Assay, and DNA Binding Studies
title Design and Synthesis of Carbothioamide/Carboxamide-Based Pyrazoline Analogs as Potential Anticancer Agents: Apoptosis, Molecular Docking, ADME Assay, and DNA Binding Studies
title_full Design and Synthesis of Carbothioamide/Carboxamide-Based Pyrazoline Analogs as Potential Anticancer Agents: Apoptosis, Molecular Docking, ADME Assay, and DNA Binding Studies
title_fullStr Design and Synthesis of Carbothioamide/Carboxamide-Based Pyrazoline Analogs as Potential Anticancer Agents: Apoptosis, Molecular Docking, ADME Assay, and DNA Binding Studies
title_full_unstemmed Design and Synthesis of Carbothioamide/Carboxamide-Based Pyrazoline Analogs as Potential Anticancer Agents: Apoptosis, Molecular Docking, ADME Assay, and DNA Binding Studies
title_short Design and Synthesis of Carbothioamide/Carboxamide-Based Pyrazoline Analogs as Potential Anticancer Agents: Apoptosis, Molecular Docking, ADME Assay, and DNA Binding Studies
title_sort design and synthesis of carbothioamide/carboxamide-based pyrazoline analogs as potential anticancer agents: apoptosis, molecular docking, adme assay, and dna binding studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260921/
https://www.ncbi.nlm.nih.gov/pubmed/35811873
http://dx.doi.org/10.1021/acsomega.2c02033
work_keys_str_mv AT ranamanish designandsynthesisofcarbothioamidecarboxamidebasedpyrazolineanalogsaspotentialanticanceragentsapoptosismoleculardockingadmeassayanddnabindingstudies
AT faizanmdimam designandsynthesisofcarbothioamidecarboxamidebasedpyrazolineanalogsaspotentialanticanceragentsapoptosismoleculardockingadmeassayanddnabindingstudies
AT darsajadhussain designandsynthesisofcarbothioamidecarboxamidebasedpyrazolineanalogsaspotentialanticanceragentsapoptosismoleculardockingadmeassayanddnabindingstudies
AT ahmadtanveer designandsynthesisofcarbothioamidecarboxamidebasedpyrazolineanalogsaspotentialanticanceragentsapoptosismoleculardockingadmeassayanddnabindingstudies
AT rahisuddin designandsynthesisofcarbothioamidecarboxamidebasedpyrazolineanalogsaspotentialanticanceragentsapoptosismoleculardockingadmeassayanddnabindingstudies